IMUC

ImmunoCellular Therapeutics, Ltd.
IMUC

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

IMUC was delisted on the 16th of October, 2018.

Back to rankings

27 hedge funds and large institutions have $405K invested in ImmunoCellular Therapeutics, Ltd. in 2018 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
27
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$27.9K
2
+$13K
3
+$7K
4
UBS Group
UBS Group
Switzerland
+$5.38K
5
NFG
Next Financial Group
Texas
+$1K

Top Sellers

1
-$14.3K
2
-$11.2K
3
-$250
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$254K
2
$60K
3
$18K
4
$15K
5
$15K
6
$13K
7
$12K
8
$8K
9
$7K
10
$2K
11
$1K
12
$14
13
$1